Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Henson

Showing results (71-80 of 113) with videos related to

Pageof 12
Sort By:
Diabetic Medicine : a Journal of the British Diabetic Association|September 3, 2016
Walking Away from Type 2 diabetes: a cluster randomized controlled trialT Yates, C L Edwardson, J Henson, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|February 1, 1987
Severe pulmonary hypertension and arterial adventitial changes in newborn calves at 4,300 mK R Stenmark, J Fasules, D M Hyde, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 14, 2019
Association of depression and anxiety with clinical, sociodemographic, lifestyle and environmental factors in South Asian and white European individuals at high risk of diabetesC Razieh, K Khunti, M J Davies, et al.
Journal of Public Health (Oxford, England)|January 11, 2017
The impact of neighbourhood walkability on the effectiveness of a structured education programme to increase objectively measured walkingP Carter, D H Bodicoat, A Jones, et al.
Brain and Behavior|December 31, 2024
The Health-Related Quality of Life Impact of the COVID-19 Pandemic on People Living with Multiple Sclerosis and the General Population: A Comparative Study Utilizing the EQ-5D-5L with Psychosocial Bolt-OnsGlen J Henson, Ingrid van der Mei, Bruce V Taylor, et al.
Pharmacoeconomics|December 31, 2024
Correction: Estimation of Transition Probabilities from a Large Cohort (> 6000) of Australians Living with Multiple Sclerosis (MS) for Changing Disability Severity Classifications, MS Phenotype, and Disease-Modifying Therapy ClassificationsJulie A Campbell, Glen J Henson, Valery Fuh Ngwa, et al.
The Journal of Laboratory and Clinical Medicine|August 1, 1978
Variability in the interaction of beta-thalassemia with the alpha-chain variants Hb G-Philadelphia and Hb RampaT H Huisman, M E Gravely, J Henson, et al.
Chemical Communications (Cambridge, England)|July 25, 2012
Investigation of formally zerovalent Triphos iron complexesTufan K Mukhopadhyay, Russell K Feller, Francisca N Rein, et al.
Pharmacoeconomics|August 2, 2024
Estimation of Transition Probabilities from a Large Cohort (> 6000) of Australians Living with Multiple Sclerosis (MS) for Changing Disability Severity Classifications, MS Phenotype, and Disease-Modifying Therapy ClassificationsJulie A Campbell, Glen J Henson, Valery Fuh Ngwa, et al.
Health and Quality of Life Outcomes|October 1, 2024
The subjective wellbeing of people living with Multiple Sclerosis in Australia: insights from the Personal Wellbeing IndexGlen J Henson, Ingrid van der Mei, Bruce V Taylor, et al.
Pageof 12

Showing results (71-80 of 113) with videos related to

Sort By:
Pageof 12
Diabetic Medicine : a Journal of the British Diabetic Association|September 3, 2016
Walking Away from Type 2 diabetes: a cluster randomized controlled trialT Yates, C L Edwardson, J Henson, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|February 1, 1987
Severe pulmonary hypertension and arterial adventitial changes in newborn calves at 4,300 mK R Stenmark, J Fasules, D M Hyde, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 14, 2019
Association of depression and anxiety with clinical, sociodemographic, lifestyle and environmental factors in South Asian and white European individuals at high risk of diabetesC Razieh, K Khunti, M J Davies, et al.
Journal of Public Health (Oxford, England)|January 11, 2017
The impact of neighbourhood walkability on the effectiveness of a structured education programme to increase objectively measured walkingP Carter, D H Bodicoat, A Jones, et al.
Brain and Behavior|December 31, 2024
The Health-Related Quality of Life Impact of the COVID-19 Pandemic on People Living with Multiple Sclerosis and the General Population: A Comparative Study Utilizing the EQ-5D-5L with Psychosocial Bolt-OnsGlen J Henson, Ingrid van der Mei, Bruce V Taylor, et al.
Pharmacoeconomics|December 31, 2024
Correction: Estimation of Transition Probabilities from a Large Cohort (> 6000) of Australians Living with Multiple Sclerosis (MS) for Changing Disability Severity Classifications, MS Phenotype, and Disease-Modifying Therapy ClassificationsJulie A Campbell, Glen J Henson, Valery Fuh Ngwa, et al.
The Journal of Laboratory and Clinical Medicine|August 1, 1978
Variability in the interaction of beta-thalassemia with the alpha-chain variants Hb G-Philadelphia and Hb RampaT H Huisman, M E Gravely, J Henson, et al.
Chemical Communications (Cambridge, England)|July 25, 2012
Investigation of formally zerovalent Triphos iron complexesTufan K Mukhopadhyay, Russell K Feller, Francisca N Rein, et al.
Pharmacoeconomics|August 2, 2024
Estimation of Transition Probabilities from a Large Cohort (> 6000) of Australians Living with Multiple Sclerosis (MS) for Changing Disability Severity Classifications, MS Phenotype, and Disease-Modifying Therapy ClassificationsJulie A Campbell, Glen J Henson, Valery Fuh Ngwa, et al.
Health and Quality of Life Outcomes|October 1, 2024
The subjective wellbeing of people living with Multiple Sclerosis in Australia: insights from the Personal Wellbeing IndexGlen J Henson, Ingrid van der Mei, Bruce V Taylor, et al.
Pageof 12